IMBRUVICA 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets *

  • Company:

    Janssen Sciences Ireland
  • Status:

    No Recent Update
  • Legal Category:

    Product subject to medical prescription which may not be renewed (A)
  • Active Ingredient(s):

    *Additional information is available within the SPC or upon request to the company

  • What is a Patient Information leaflet and why is it useful?

    A Patient Information Leaflet (PIL) is the leaflet containing information on taking or using a medicine for patients, included with medicine packaging. It is written by pharmaceutical companies as a patient version of the Summary of Product Characteristics (SPC). Changes to the PIL after your medicine was packed may mean the version on medicines.ie may differ from the version found with your medicine.

  • IRE-NI_Imbruvica tablets-PIL-C11-PSUSA-Clean-20Aug21

    Last updated: 01/09/21